David Greenstein, MD

Bimekizumab Superior to Placebo in Patients with Moderate-to-Severe Psoriasis
UCB recently announced the positive results of the
Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis
Photo: courtesy of The U.S. Food and Drug Administ
Prurigo Nodularis: Behind the Itch
Defining Prurigo Nodularis Prurigo Nodularis (PN)

Proud sponsor of “Shades of Hope”
Improving Melanoma Prevention, through A
New Portsmouth, NH office coming soon!
ALLCUTIS Research, Inc. is pleased to announce we

departments: Dermatology

positions: Dermatology

degree: MD

Social media & sharing icons powered by UltimatelySocial